Abstract: Provided are electric vehicle charging systems (EV charging systems) and methods of operating such systems for charging electric vehicles (EVs). A system, which may be referred to as electric vehicle service equipment (EVSE), comprises one or more EV charging ports (e.g., charge handles) for connecting to EVs. The system may include various features to identify specific EVs. The system also includes a grid connector for connecting to an external power grid and, in some examples, to monitor the power grid conditions (e.g., voltage, AC frequency). The system also includes a system controller, configured to control the power output at each EV charging port based on, e.g., vehicle charging requirements and/or available grid power. The system can also include an integrated battery, serving as a backup and/or an addition to the power grid. Furthermore, in some examples, the system includes a solar connector (e.g., with an integrated inverter) for connection to an external solar array.

Abstract: The invention provides a (drug-containing) lipid nanoparticle with: (i) at least one phospholipid; (ii) at least one lysolipid; and (iii) at least one phospholipid comprising a hydrophilic polymer; and (iv) at least one structural lipid of formula (I) which has the following general structure: wherein R and R? are long hydrocarbyl hydrophobic chains, Y is a linker element, and PHG is a polar head group described as large according to its van der Waals radius, and which is different from the phospholipid (i). The lipid nanoparticle can release a drug (or API) from within the lipid nanoparticle as a result of focused ultrasound (FUS) applied continuously, at least twice, to a desired part of the body to induce hyperthermia (an increase in temperature). FUS is applied after the lipid nanoparticle containing the drug has been administered to the live subject, and causes controlled release of the drug at the desired site of the body.

Abstract: Various devices, apparatuses, and methods for transseptal puncture and crossing are disclosed herein. A transseptal puncture and crossing device can include novel puncture member having a crossing coil mated to a body portion to be able to both cross a tissue and allow a wire or guard be inserted through the puncture member. Though not required, the puncture member can have one or more of novel features, including a tapered coil portion, a transition cutter, a gripper coil portion, an atraumatic guard, and a shaped cutting wire. Methods for transseptal punctures and crossing include adding rotation, oscillation and/or ultrasound to a transseptal puncture device.

Abstract: Disclosed herein are embodiments of a method of treating a tissue of the heart, for example and without limitation, a tissue of the left atrial appendage, including twisting at least a portion of a tissue of the left atrial appendage to constrict an ostium of the left atrial appendage, and ablating at least a portion of the tissue of the heart, which can include a tissue of the left atrial appendage, the ostium of the left atrial appendage, and/or at least a portion of a tissue adjacent to the ostium of the left atrial appendage.

Abstract: A device for treating a left atrial appendage, including an implant having a contact member configured to engage an inside tissue surface of the left atrial appendage and configured to rotate in at least a first direction from a first position to at least a second position so as to twist the left atrial appendage when the contact member is engaged with an inside tissue surface of the left atrial appendage. Some embodiments can also include a securing element configured to move between a first position in which the securing element is decoupled from the contact member and a second position in which the securing element is coupled with the contact member.

Abstract: A light emitting device is disclosed that is configured to be attached to a drum of a clothes dryer. The device includes a device body having a first portion and a second portion that is rotatably coupled to the first portion. The light emitting device further includes a light source supported by the device body, and a power source supported by the device body. The power source is electrically connected to the light source so as to power the light source.

Abstract: The invention relates to a hyperthermia (focused ultrasound—FUS) method where an energy source is applied, repeatedly, to a desired part of the body to induce hyperthermia, e.g. using image guidance. Hyperthermia is applied after a drug or biopharmaceutical (API) and/or their labelled equivalents (theranostics) and/or their drug delivery systems has been administered to the live subject to cause the enhanced tissue distribution and/or controlled release of the drug, previously encapsulated in thermo-sensitive (lipid nano)particles, to a desired site of the body. Hyperthermia (Ultrasound) is then halted, and the site of interest. Hyperthermia is then applied again using image guidance to monitor drug's accumulation in the tissue. The drug and or the drug delivery system are also labelled (for imaging) to allow real time monitoring and modulation of the API in the human body which can be used to direct and guide the FUS at the site of interest.

Abstract: The invention provides a (drug-containing) lipid nanoparticle with: (i) at least one phospholipid; (ii) at least one lysolipid; and (iii) at least one phospholipid comprising a hydrophilic polymer; and (iv) at least one structural lipid of formula (I) which has the following general structure: wherein R and R? are long hydrocarbyl hydrophobic chains, Y is a linker element, and PHG is a polar head group described as large according to its van der Waals radius, and which is different from the phospholipid (i). The lipid nanoparticle can release a drug (or API) from within the lipid nanoparticle as a result of focused ultrasound (FUS) applied continuously, at least twice, to a desired part of the body to induce hyperthermia (an increase in temperature). FUS is applied after the lipid nanoparticle containing the drug has been administered to the live subject, and causes controlled release of the drug at the desired site of the body.